Loading...
Found 389 oncology trials
A listing of oncology medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
- Sort by
- Last updated
Please refer to Section 6 of the full protocol (Study Objectives). Please refer to Section 12 of the full protocol (Statistical Analysis). Please refer to Section 12 of the full protocol (Statistical Analysis).
Please refer to Section 6 of the full protocol (Study Objectives). Please refer to Section 13 of the full protocol (Statistical Analysis). Please refer to Section 13 of the full protocol (Statistical Analysis).
See Section 2.1 See section 5.1 See section 5.1
To investigate the possible re-activation of CAR T-cells in response to interventions subsequent to CAR T-cell infusion.
To investigate immunologic changes in Hodgkin Lymphoma patients treated with itacitinib (a JAK inhibitor) in combination with everolimus (an mTOR inhibitor).
To investigate the efficacy and expansion of CAR T-cells manufactured in an expedited fashion in patient-derived xenograft models (mice).
To determine potential mechanisms of CD20 loss after CD20-directed therapy in non-Hodgkin lymphomas.
To identify novel gene and protein targets in biospecimens of patients with EBV-associated lymphoproliferative disorders who are enrolled to L-RAD (IRB #832203).
The objective is to obtain clinical (phenotypic) and laboratory (biomarker) data during immediate drug hypersensitivity reactions in L-RAD patients receiving anti-CD19 or anti-CD20 bispecific antibodies or monoclonal antibodies to classify them as a(an): (1) type 1 immediate hypersensitivity reaction (allergic) (2) cytokine release syndrome (CRS) (3) infusion-related reaction (IRR) (4) …
Investigate the involvement of the microbiome and associated metabolites in ovarian cancer. Generate a predictive model for ovarian cancer risk and progression. The primary outcome variable is metabolite identification and analysis. The secondary outcome variable is cancer risk as related to metabolites and genetic variants.
Please choose between Voice or SMS based delivery of verification code
or